CHEBI:145371 - binimetinib

ChEBI IDCHEBI:145371
ChEBI Namebinimetinib
Stars
DefinitionA member of the class of benzimidazoles that is 1-methyl-1H-benzimidazole which is substituted at positions 4, 5, and 6 by fluorine, (4-bromo-2-fluorophenyl)nitrilo, and N-(2-hydroxyethoxy)aminocarbonyl groups, respectively. It is a MEK1 and MEK2 inhibitor (IC50= 12 nM). Approved by the FDA for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation in combination with encorafenib.
Last Modified14 November 2019
SubmitterAdnan
DownloadsMolfile
FormulaC17H15BrF2N4O3
Net Charge0
Average Mass441.232
Monoisotopic Mass440.02956
SMILESCn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21
InChIInChI=1S/C17H15BrF2N4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)
InChIKeyACWZRVQXLIRSDF-UHFFFAOYSA-N
Wikipedia
Roles Classification
Chemical Role:
Bronsted base  A molecular entity capable of accepting a hydron from a donor (Brønsted acid).
Biological Roles:
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor  An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of mitogen-activated protein kinase (EC 2.7.11.24).
apoptosis inducer  Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
Application:
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
ChEBI Ontology
Outgoing Relation(s)
binimetinib (CHEBI:145371) has role antineoplastic agent (CHEBI:35610)
binimetinib (CHEBI:145371) has role apoptosis inducer (CHEBI:68495)
binimetinib (CHEBI:145371) has role EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor (CHEBI:79091)
binimetinib (CHEBI:145371) is a benzimidazoles (CHEBI:22715)
binimetinib (CHEBI:145371) is a bromobenzenes (CHEBI:37149)
binimetinib (CHEBI:145371) is a hydroxamic acid ester (CHEBI:75606)
binimetinib (CHEBI:145371) is a monofluorobenzenes (CHEBI:83575)
binimetinib (CHEBI:145371) is a secondary amino compound (CHEBI:50995)
IUPAC Name 
5-(4-bromo-2-fluoroanilino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide
INNs  Source
binimetinibWHO MedNet
binimetinibumWHO MedNet
binimétinibWHO MedNet
binimetinibWHO MedNet
Synonyms  Source
MEK-162DrugBank
ARRY-438162DrugBank
MEK162DrugBank
NVP-MEK162DrugBank
ARRY-162DrugBank
5-[(4-bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboxamideDrugBank
Brand Name  Source
MektoviKEGG DRUG
Manual XrefsDatabases
DB11967DrugBank
D10604KEGG DRUG
BinimetinibWikipedia
LSM-45640LINCS
Registry NumbersSources
CAS:606143-89-9ChemIDplus
Citations